Date Filed | Type | Description |
08/08/2023 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
08/08/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
08/08/2023 |
8-K
| Quarterly results
Docs:
|
"Danimer Scientific Announces Second Quarter 2023 Results -- Issues Separate Release Announcing Accepted Part 2 Application for DoE Loan Guarantee -- -- Expands Portfolio with Resins for Protective Films, Shrink Wrap & Produce Bags -- BAINBRIDGE, GA – August 8, 2023 – Danimer Scientific, Inc. , a leading next-generation bioplastics company focused on the development and production of highly engineered biodegradable materials, today announced financial results for its second quarter, ended June 30, 2023. Danimer announced, in a separate release also issued after the close of market today, the acceptance of its Part II Application by the U.S. Department of Energy under the Title XVII Loan Guarantee. The Company has been invited into the confirmatory due diligence and term sheet negotiation pr...",
"Second Quarter 2023 Earnings Presentation August 8, 2023" |
|
06/05/2023 |
4
| Noda Isao (Director) has filed a Form 4 on Danimer Scientific, Inc.
Txns:
| Granted 16,611 restricted stock units
@ $0 |
|
06/05/2023 |
4
| HENDRIX RICHARD J (Director) has filed a Form 4 on Danimer Scientific, Inc.
Txns:
| Granted 18,272 restricted stock units
@ $0 |
|
06/05/2023 |
4
| Hunt Gregory W. (Director) has filed a Form 4 on Danimer Scientific, Inc.
Txns:
| Granted 23,256 restricted stock units
@ $0 |
|
06/05/2023 |
4
| Tilley Allison Leopold (Director) has filed a Form 4 on Danimer Scientific, Inc.
Txns:
| Granted 16,611 restricted stock units
@ $0 |
|
06/05/2023 |
4
| COHEN CYNTHIA R (Director) has filed a Form 4 on Danimer Scientific, Inc.
Txns:
| Granted 18,272 restricted stock units
@ $0 |
|
06/05/2023 |
4
| Pratt Stuart W (Director) has filed a Form 4 on Danimer Scientific, Inc.
Txns:
| Granted 16,611 restricted stock units
@ $0 |
|
06/05/2023 |
4
| Calhoun Philip Gregory (Director) has filed a Form 4 on Danimer Scientific, Inc.
Txns:
| Granted 16,611 restricted stock units
@ $0 |
|
06/05/2023 |
4
| AMBOIAN JOHN P (Director) has filed a Form 4 on Danimer Scientific, Inc.
Txns:
| Granted 26,578 restricted stock units
@ $0 |
|
06/05/2023 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
06/05/2023 |
8-K
| Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits Interactive Data |
05/17/2023 |
144
| Form 144 - Report of proposed sale of securities: |
05/17/2023 |
4
| Tuten Scott (Chief Marketing Officer) has filed a Form 4 on Danimer Scientific, Inc.
Txns:
| Sold 10,000 shares
@ $3.381, valued at
$33.8k
|
|
05/15/2023 |
4
| Noda Isao (Director) has filed a Form 4 on Danimer Scientific, Inc.
Txns:
| Granted 441 shares
@ $0 |
|
05/12/2023 |
4
| Van Trump Phillip D (Chief Technology Officer) has filed a Form 4 on Danimer Scientific, Inc.
Txns:
| Granted 199 shares
@ $0 |
|
05/12/2023 |
4
| Tuten Scott (Chief Marketing Officer) has filed a Form 4 on Danimer Scientific, Inc.
Txns:
| Granted 1,268 shares
@ $0 |
|
05/12/2023 |
4
| Pratt Stuart W (Director) has filed a Form 4 on Danimer Scientific, Inc.
Txns:
| Granted 14,868 shares
@ $0 |
|
05/12/2023 |
4
| CROSKREY STEPHEN (CEO & Chairman of the Board) has filed a Form 4 on Danimer Scientific, Inc.
Txns:
| Granted 39,333 shares
@ $0 |
|
05/12/2023 |
4
| Calhoun Philip Gregory (Director) has filed a Form 4 on Danimer Scientific, Inc.
Txns:
| Granted 2,055 shares
@ $0 Granted 27,986 shares
@ $0 Granted 545 shares
@ $0 |
|
05/10/2023 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
05/10/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
04/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/17/2023 |
144
| Form 144 - Report of proposed sale of securities: |
04/17/2023 |
ARS
| Form ARS - Annual Report to Security Holders: |
04/17/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
04/17/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
03/31/2023 |
4/A
| CROSKREY STEPHEN (CEO & Chairman of the Board) has filed a Form 4 on Danimer Scientific, Inc.
Txns:
| Granted 750,000 options
@ $2.58, valued at
$1.9M
Granted 300,000 options
@ $7.5, valued at
$2.3M
Granted 385,000 options to buy
@ $0 |
|
03/28/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
03/28/2023 |
8-K
| Quarterly results |
03/21/2023 |
4
| Tuten Scott (Chief Marketing Officer) has filed a Form 4 on Danimer Scientific, Inc.
Txns:
| Sold 10,000 shares
@ $2.0999, valued at
$21k
|
|
03/20/2023 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
03/20/2023 |
8-K
| Quarterly results |
|